by Eileen Brewer | Sep 20, 2024 | News
Doctors across the country are beginning to look beyond their prescription pads to explore new treatments for chronic pain management: psychedelics.
by Eileen Brewer | Jun 13, 2023 | News
Lewis et al. perform an extensive pharmacological characterization of 2-Br-LSD, finding distinct aminergic GPCR polypharmacology, including 5-HT2A partial agonism and lack of psychedelic-like effects in vivo. Further, 2-Br-LSD induces dendritogenesis and spinogenesis...
by Eileen Brewer | Mar 3, 2023 | News
Hear the latest headache medical updates in our ononce-a-month HeadWise Medical News Update Episode (episode #149) with headache specialist Tim Smith, MD.
by Eileen Brewer | Feb 9, 2023 | News
NatGeo has a new episode of their series entitled, National Geographic Investigates: LSD and the Psychedelic Revolution. Clusterbusters was excited to participate, and our segment was filmed at the 2022 US Clusterbusters Patient Conference. From Hulu, “For years...
by Eileen Brewer | Sep 30, 2022 | News
Backed by three top psychiatrists, 161 cluster headache sufferers in the UK have written an open letter to Home Office ministers Savid Javid and Kit Malthouse calling for politicians to reschedule psilocybin.